Manchester research leads to NHS roll out of life-saving treatment for babies with rare disease
Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.
Read moreBabies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.
Read moreA special event took place to celebrate 10 years of MFT’s involvement in ‘Enroll-HD’ – a global registry study for Huntington's disease.
Read moreFor a nine-year old boy and his family, being part of Duchenne Muscular Dystrophy clinical research at NIHR Manchester CRF at Royal Manchester Children's Hospital has been ‘amazing,’ for many reasons.
Read more10 MFT clinicians are among 15 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC) as Honorary Clinical Chairs for 2023
Read moreA major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.
Read moreThe NIHR has awarded more than £96 million to 93 NHS organisations as part of a capital investment – with £2.26 million awarded to MFT.
Read moreThe Mayor of Greater Manchester, Andy Burnham, officially opened a successful launch event to celebrate the multi-million-pound funding boost for the NIHR Manchester BRC and CRF
Read moreThe world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.
Read more